News & Events

Zahrawi Group took the lead since the COVID-19 Pandemic in 2020 to provide all the possible solutions for the COVID-19 patients. Antibody level testing helps clinicians to establish whether patients have immunity against COVID-19 which impacts the nature of the treatment and the vaccine needed for them. DiaSorin provided the most comprehensive, accurate, and quantitative […]

Read more

After a successful first participation with a Zahrawi Group stand in Medlab 2020, we were back in this year’s exhibition with our own space fully dedicated to welcome and greet our customers and partners. The exhibition took place at the Dubai World Trade Centre from January 24 to 27, 2022 under the theme of “Connect […]

Read more

As a reflection of its mission statement to providing smart solutions and innovative products to the GCC market, Zahrawi Group teams showed a strong presence alongside our partners during the Arab Health 2022, the MENA region’s leading exhibition for the healthcare industry that took place on 24-27 January at the Dubai World Trade Centre. The […]

Read more

We are pleased to announce that our Molecular, Immunology and Microbiology team in UAE has received the “Growth Champion Genomics 2021” award handed by Agilent during the CY 2021 Result & Awards Celebration on the 17th January 2022. United Arab Emirates is a high potential market where Zahrawi Group have excelled and registered the highest […]

Read more

We are proud to announce that our Structural Heart & Neuromodulation unit in KSA has successfully implanted a Watchman FLX device from our partner Boston Scientific at National Guard Health Affairs Jeddah (King Faisal Cardiac Center), where Dr. Abdullah Alsaeidi, Dr. Wail Alkashkari, Dr. Fahad Almehmadi and the Cath lab team operated on a 60-years+ […]

Read more